GB0205649D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0205649D0
GB0205649D0 GB0205649A GB0205649A GB0205649D0 GB 0205649 D0 GB0205649 D0 GB 0205649D0 GB 0205649 A GB0205649 A GB 0205649A GB 0205649 A GB0205649 A GB 0205649A GB 0205649 D0 GB0205649 D0 GB 0205649D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0205649A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
GlaxoSmithKline SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline SpA filed Critical GlaxoSmithKline SpA
Priority to GB0205649A priority Critical patent/GB0205649D0/en
Priority to PCT/EP2002/004066 priority patent/WO2002083663A1/en
Priority to PCT/EP2002/004070 priority patent/WO2002083664A1/en
Priority to EP02761911A priority patent/EP1385839B1/en
Priority to EP02735247A priority patent/EP1377567B1/en
Priority to AT02735247T priority patent/ATE313539T1/en
Priority to EP06075240A priority patent/EP1659120A1/en
Priority to DE60208178T priority patent/DE60208178T2/en
Priority to JP2002581419A priority patent/JP2004525184A/en
Priority to ES02735247T priority patent/ES2254688T3/en
Priority to DE60209362T priority patent/DE60209362T2/en
Priority to AT02761911T priority patent/ATE318266T1/en
Priority to ES02761911T priority patent/ES2259096T3/en
Priority to US10/474,542 priority patent/US20040152726A1/en
Priority to JP2002581418A priority patent/JP2004525183A/en
Publication of GB0205649D0 publication Critical patent/GB0205649D0/en
Priority to US11/100,256 priority patent/US20050176762A1/en
Priority to US11/426,956 priority patent/US20060229315A1/en
Priority to US11/685,380 priority patent/US20070161647A1/en
Priority to US11/768,338 priority patent/US20070259882A1/en
Ceased legal-status Critical Current

Links

GB0205649A 2001-04-11 2002-03-11 Novel compounds Ceased GB0205649D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0205649A GB0205649D0 (en) 2002-03-11 2002-03-11 Novel compounds
ES02735247T ES2254688T3 (en) 2001-04-11 2002-04-11 DERIVATIVES OF QUINOLINA-4-CARBOXAMIDE AS ANTAGONISTS OF THE NK-3 AND NK-2 RECEPTORS.
DE60209362T DE60209362T2 (en) 2001-04-11 2002-04-11 3-SUBSTITUTED CHINOLIN-4-CARBOXYLIC ACID AMID DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS
EP02761911A EP1385839B1 (en) 2001-04-11 2002-04-11 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
EP02735247A EP1377567B1 (en) 2001-04-11 2002-04-11 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
AT02735247T ATE313539T1 (en) 2001-04-11 2002-04-11 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS
EP06075240A EP1659120A1 (en) 2001-04-11 2002-04-11 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
DE60208178T DE60208178T2 (en) 2001-04-11 2002-04-11 CHINOLIN-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS
JP2002581419A JP2004525184A (en) 2001-04-11 2002-04-11 3-Substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
PCT/EP2002/004066 WO2002083663A1 (en) 2001-04-11 2002-04-11 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
PCT/EP2002/004070 WO2002083664A1 (en) 2001-04-11 2002-04-11 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
AT02761911T ATE318266T1 (en) 2001-04-11 2002-04-11 3-SUBSTITUTED QUINOLINE-4-CARBONIC ACID AMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS
ES02761911T ES2259096T3 (en) 2001-04-11 2002-04-11 DERIVATIVES OF QUINOLINA-4-CARBOXAMIDE 3-REPLACED AS ANTAGONISTS OF THE NK-3 AND NK-2 RECEPTORS.
US10/474,542 US20040152726A1 (en) 2001-04-11 2002-04-11 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
JP2002581418A JP2004525183A (en) 2001-04-11 2002-04-11 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
US11/100,256 US20050176762A1 (en) 2001-04-11 2005-04-06 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
US11/426,956 US20060229315A1 (en) 2001-04-11 2006-06-28 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
US11/685,380 US20070161647A1 (en) 2001-04-11 2007-03-13 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS
US11/768,338 US20070259882A1 (en) 2001-04-11 2007-06-26 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0205649A GB0205649D0 (en) 2002-03-11 2002-03-11 Novel compounds

Publications (1)

Publication Number Publication Date
GB0205649D0 true GB0205649D0 (en) 2002-04-24

Family

ID=9932696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0205649A Ceased GB0205649D0 (en) 2001-04-11 2002-03-11 Novel compounds

Country Status (1)

Country Link
GB (1) GB0205649D0 (en)

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0201231D0 (en) Novel compounds
GB0201357D0 (en) Novel compounds
GB0202140D0 (en) Novel compounds
GB0202141D0 (en) Novel compounds
GB0202217D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds
GB0202442D0 (en) Novel compounds
GB0202636D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0200787D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)